FBTAX
Price
$31.26
Change
+$0.55 (+1.79%)
Updated
Sep 5 closing price
Net Assets
1.46B
LHCIX
Price
$19.97
Change
+$0.12 (+0.60%)
Updated
Sep 4 closing price
Net Assets
7.8M
Interact to see
Advertisement

FBTAX vs LHCIX

Header iconFBTAX vs LHCIX Comparison
Open Charts FBTAX vs LHCIXBanner chart's image
Fidelity Advisor Biotechnology A
Price$31.26
Change+$0.55 (+1.79%)
VolumeN/A
Net Assets1.46B
Lord Abbett Health Care I
Price$19.97
Change+$0.12 (+0.60%)
VolumeN/A
Net Assets7.8M
FBTAX vs LHCIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FBTAX vs. LHCIX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Buy and LHCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.46B vs. LHCIX (7.8M). FBTAX pays higher dividends than LHCIX: FBTAX (2.59) vs LHCIX (0.56). FBTAX was incepted earlier than LHCIX: FBTAX (25 years) vs LHCIX (6 years). LHCIX (3.09) is less costly to investors than FBTAX (0.96). LHCIX is a more actively managed with annual turnover of: 88.00 vs. FBTAX (73.00). FBTAX has a lower initial minimum investment than LHCIX: FBTAX (0) vs LHCIX (1000000). LHCIX annual gain was more profitable for investors over the last year : -0.99 vs. FBTAX (-2.11). LHCIX return over 5 years is better than : 10.87 vs. FBTAX (8.83).
FBTAXLHCIXFBTAX / LHCIX
Total Expense Ratio0.960.78123%
Annual Report Gross Expense Ratio0.963.0931%
Fund Existence25 years6 years-
Gain YTD14.8843.721400%
Front Load6%N/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B7.8M18,753%
Annual Yield % from dividends2.590.56465%
Returns for 1 year-2.11-0.99212%
Returns for 3 years38.3319.75194%
Returns for 5 years8.8310.8781%
Returns for 10 years12.49N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEOVF0.13N/A
+3.89%
SERNOVA BIOTHERAPEUTICS INC.
WXXWY9.350.19
+2.07%
Wuxi Biologics (Cayman) Inc
BWEL507.000.75
+0.15%
Boswell (J.G.) Co.
HAPVD10.01N/A
N/A
HAPVIDA PARTICIPACOES E INVESTIMENTOS SA
AXVEF0.18N/A
N/A
CDN MAVERICK CAP CORP.